Home LiteratureArticle Details
PMID: 2215849 Published · ppublish English Journal Article Review

The serotonin 5-HT1D receptor: a progress review.

Neurochemical research ·Vol. 15 ·No. 6 ·1990-06-00 ·Pages 567-82

Waeber C, Schoeffter P, Hoyer D, Palacios JM

Abstract

Most of the known neurotransmitters interact with more than one type of receptor. Some of them even dispose of receptor subtypes to exert their actions. Serotonin, far from being an exception to that, possesses at least 3 classes of receptors, which have all been reported to be heterogeneous, although convincing data only exist for the 5-HT1 class. This name has been proposed in 1979, two years before the introduction of 'A' and 'B' in the nomenclature to account for the observed heterogeneity of these sites. The 5-HT1C receptor subtype was first described in 1984 and the last member of the family, named 5-HT1D, was characterized in 1987. The pharmacological profiles, the signal transducing systems and the anatomical localizations, both at the regional and cellular levels, of all these subtypes have been investigated and possible functions have been proposed for each of them. Moreover, last and most definitive demonstration of the subtype individuality, the gene or complementary DNA coding for the 5-HT1A and 5-HT1C (and 5-HT2) receptors have been cloned and sequenced. Such data are still missing for 5-HT1D (and 5-HT1B) receptors, but will certainly be provided in the next few years. However and waiting for this decisive clue, the characterization of the 5-HT1D subtype leaves no doubt concerning its significance as a function 5-HT receptor. This review will concentrate on the characteristics of this subtype of 5-HT receptor.

MeSH Terms
Animals Brain Chemistry Humans Receptors, Serotonin/analysis,physiology Second Messenger Systems Serotonin/metabolism Tissue Distribution
Chemicals
Receptors, Serotonin Serotonin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Waeber C
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.
Schoeffter P
Hoyer D
Palacios J M
References (79)
79 references, click to expand
  1. Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain.
    Synapse. 1987;1(1):124-30 PMID: 3145578
  2. 5.HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography.
    Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):486-94 PMID: 2533325
  3. 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization.
    Naunyn Schmiedebergs Arch Pharmacol. 1989 Mar;339(3):252-8 PMID: 2725702
  4. Prosencephalic pathways related to the paleostriatum of the pigeon (Columba livia).
    Brain Res. 1978 May 26;147(2):205-21 PMID: 647399
  5. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.
    Lancet. 1988 Jun 11;1(8598):1309-11 PMID: 2897560
  6. A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex.
    Eur J Pharmacol. 1988 Nov 15;157(1):101-7 PMID: 3234493
  7. Agonist-induced phosphoinositide hydrolysis in choroid plexus.
    J Neurochem. 1986 Dec;47(6):1754-60 PMID: 3021903
  8. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?
    Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):675-83 PMID: 2770889
  9. LY165163 and 8-OH-DPAT have agonist effects on a serotonin responsive muscle of Aplysia.
    Eur J Pharmacol. 1987 Jul 9;139(2):247-50 PMID: 2958301
  10. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
    Nature. 1987 Dec 24-31;330(6150):746-8 PMID: 3696238
  11. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
    Eur J Pharmacol. 1985 Nov 26;118(1-2):1-12 PMID: 3002805
  12. Serotonin content of some mammalian tissues and urine and a method for its determination.
    Am J Physiol. 1953 Oct;175(1):157-61 PMID: 13114371
  13. The molecular basis of muscarinic receptor diversity.
    Trends Neurosci. 1989 Apr;12(4):148-51 PMID: 2470172
  14. Evidence for hyperdensity of 5HT1B binding sites in the substantia nigra of the rat after 5,7-dihydroxytryptamine intraventricular injection.
    Neurochem Int. 1986;9(1):191-200 PMID: 20493117
  15. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain.
    Trends Pharmacol Sci. 1989 Apr;10(4):130-2 PMID: 2665245
  16. Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease.
    J Neurochem. 1977 Apr;28(4):867-9 PMID: 142820
  17. Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist.
    Eur J Pharmacol. 1987 Apr 7;136(1):1-9 PMID: 3496228
  18. Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors.
    Neuroscience. 1987 Apr;21(1):97-122 PMID: 2955249
  19. Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors.
    Neuroscience. 1987 Apr;21(1):123-39 PMID: 3601071
  20. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
    Brain Res. 1983 Sep 26;275(2):321-8 PMID: 6626985
  21. 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies.
    Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):479-85 PMID: 2533324
  22. Detection and characterization of a 5HT1D serotonin receptor-GTP binding protein interaction in porcine and bovine brain.
    Synapse. 1989;3(4):325-30 PMID: 2525822
  23. Identification of 5-hydroxytryptamine1D binding sites in human brain membranes.
    Synapse. 1989;3(1):61-6 PMID: 2521959
  24. Serum vasoconstrictor (serotonin) the presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle.
    J Biol Chem. 1949 Oct;180(3):961-9 PMID: 18139191
  25. Rat brain 5-HT1C receptors are encoded by a 5-6 kbase mRNA size class and are functionally expressed in injected Xenopus oocytes.
    J Neurosci. 1987 Apr;7(4):1159-65 PMID: 2883267
  26. Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor.
    Science. 1987 Oct 30;238(4827):650-6 PMID: 2823383
  27. Purification of the substance which is responsible for the vasoconstrictor activity of serum.
    Fed Proc. 1947;6(1 Pt 2):184 PMID: 20342823
  28. Brain serotonin receptors in Huntington's disease.
    Neurochem Int. 1986;9(3):431-5 PMID: 20493143
  29. 5-HT-1a and 5-HT-1b selectivity of two phenylpiperazine derivatives: evidence for 5-HT-1b heterogeneity.
    Life Sci. 1985 Apr 1;36(13):1265-73 PMID: 3982214
  30. Two kinds of tryptamine receptor.
    Br J Pharmacol Chemother. 1957 Sep;12(3):323-8 PMID: 13460238
  31. Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiography study.
    Neuroscience. 1989;32(2):337-47 PMID: 2531301
  32. 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization.
    Trends Neurosci. 1988 Nov;11(11):496-500 PMID: 2469177
  33. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
    Mol Pharmacol. 1982 Mar;21(2):301-14 PMID: 7099138
  34. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Mol Pharmacol. 1988 Mar;33(3):303-9 PMID: 3352595
  35. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.
    Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):1-7 PMID: 2936965
  36. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
    J Pharmacol Exp Ther. 1990 Jan;252(1):387-95 PMID: 2137176
  37. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.
    Brain Res. 1985 Nov 4;346(2):205-30 PMID: 4052776
  38. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.
    Brain Res. 1985 Nov 4;346(2):231-49 PMID: 4052777
  39. Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.
    Neurology. 1986 Apr;36(4):556-60 PMID: 2938025
  40. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.
    Neuropharmacology. 1986 Jun;25(6):563-76 PMID: 2875415
  41. An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor.
    Mol Pharmacol. 1976 Mar;12(2):335-9 PMID: 4726
  42. A highly sensitive adenylate cyclase assay.
    Anal Biochem. 1974 Apr;58(2):541-8 PMID: 4827395
  43. Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.
    Neuropharmacology. 1984 Aug;23(8):993-6 PMID: 6483122
  44. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
    J Pharmacol Exp Ther. 1986 Jul;238(1):248-53 PMID: 2941565
  45. Serotonin 5-HT1D receptors in human prefrontal cortex and caudate: interaction with a GTP binding protein.
    J Neurochem. 1988 Dec;51(6):1906-12 PMID: 3141589
  46. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats.
    J Neurosci. 1986 Dec;6(12):3474-82 PMID: 2947981
  47. Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein.
    J Neurochem. 1989 Aug;53(2):465-71 PMID: 2664084
  48. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites.
    Brain Res. 1986 Jun 18;376(1):85-96 PMID: 3719375
  49. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    J Pharm Pharmacol. 1988 Aug;40(8):548-51 PMID: 2907008
  50. The striatum and substantia nigra: a commentary on their relationships.
    Neuroscience. 1979;4(10):1407-39 PMID: 233319
  51. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Neurosci Lett. 1988 Mar 10;85(3):357-62 PMID: 2966310
  52. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.
    Naunyn Schmiedebergs Arch Pharmacol. 1988 Jun;337(6):602-8 PMID: 3216894
  53. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
    Eur J Pharmacol. 1988 Jul 7;151(2):189-96 PMID: 2971554
  54. The serotonin (5-HT) autoreceptor in the hippocampus of the rabbit: role of 5-HT biophase concentration.
    Neuropharmacology. 1987 Aug;26(8):1071-80 PMID: 2958718
  55. The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor.
    Nature. 1988 Sep 22;335(6188):358-60 PMID: 3138543
  56. Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor.
    Nature. 1983 Oct 27-Nov 2;305(5937):818-23 PMID: 6688857
  57. A family of receptors coupled to guanine nucleotide regulatory proteins.
    Biochemistry. 1987 May 19;26(10):2657-64 PMID: 3038163
  58. Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes.
    Eur J Pharmacol. 1988 Nov 1;156(2):287-90 PMID: 3240771
  59. Oxymetazoline inhibits adenylate cyclase by activation of serotonin-1 receptors in the OK cell, an established renal epithelial cell line.
    Mol Pharmacol. 1988 Jul;34(1):1-7 PMID: 2839761
  60. Structure and functional expression of cloned rat serotonin 5HT-2 receptor.
    EMBO J. 1988 Dec 20;7(13):4135-40 PMID: 2854054
  61. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.
    Naunyn Schmiedebergs Arch Pharmacol. 1988 Jun;337(6):595-601 PMID: 2975354
  62. How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.
    Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):135-8 PMID: 2552330
  63. 5-HT1 receptor binding sites in the guinea pig superior colliculus are predominantly of the 5-HT1D class and are presynaptically located on primary retinal afferents.
    Brain Res. 1990 Oct 1;528(2):207-11 PMID: 2271922
  64. 5-hydroxytryptamine3 receptors in the human brain: autoradiographic visualization using [3H]ICS 205-930.
    Neuroscience. 1989;31(2):393-400 PMID: 2797443
  65. The immediate action of an intravenous injection of blood-serum.
    J Physiol. 1900 Dec 31;26(1-2):48-71 PMID: 16992567
  66. Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography.
    Neurosci Lett. 1988 May 16;88(1):11-6 PMID: 3399126
  67. [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.
    Eur J Pharmacol. 1988 Mar 29;148(2):297-9 PMID: 3378579
  68. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Eur J Pharmacol. 1985 Nov 26;118(1-2):13-23 PMID: 2935410
  69. High-affinity serotonin binding sites: autoradiographic evidence for their location on retinal afferents in the rat superior colliculus.
    Brain Res. 1986 Oct 8;384(2):205-17 PMID: 2946358
  70. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes.
    J Neurosci. 1987 Mar;7(3):894-903 PMID: 2951504
  71. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
    Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):396-402 PMID: 2586633
  72. Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS.
    Eur J Pharmacol. 1988 Jul 7;151(2):351-2 PMID: 3169128
  73. Molecular characterization of a functional cDNA encoding the serotonin 1c receptor.
    Science. 1988 Jul 29;241(4865):558-64 PMID: 3399891
  74. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins.
    Nature. 1987 Sep 3-9;329(6134):75-9 PMID: 3041227
  75. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.
    Br J Pharmacol. 1988 Aug;94(4):1123-32 PMID: 2850055
  76. GR 43175: a preferential 5-HT1D agent in monkey and human 1rains as shown by autoradiography.
    Synapse. 1989;4(2):168-70 PMID: 2551055
  77. Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein.
    Nature. 1988 Sep 15;335(6187):254-6 PMID: 3045568
  78. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Mol Pharmacol. 1979 Nov;16(3):687-99 PMID: 530254
  79. Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity.
    Science. 1988 Jun 3;240(4857):1310-6 PMID: 2836950
Article Info
Journal
Neurochemical research
Abbr.
Neurochem Res
ISSN
0364-3190
Published
1990-06-00
Pages
567-82
Language
English
Region
United States
NLM ID
7613461
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com